CVS Stock Is a Buy Ahead of Vaccine: Analyst

Author:
Publish date:
Video Duration:
48

A potential vaccine from Pfizer  (PFE) - Get Report and BioNTech  (BNTX) - Get Report has sent markets soaring Monday, but should investors look beyond the companies producing COVID vaccines to those who will distribute them? 

In a news panel featuring experts from across TheStreet, Action Alerts PLUS senior portfolio analyst Jeff Marks said he's putting his attention on CVS  (CVS) - Get Report

Marks said paired a strong earnings report, the vaccine will serve as a tailwind for CVS going forward. 

"Where are you going to go to get a vaccine. It's going to be at a CVS Health," Marks said. 

Watch our full panel for additional insight from Bob Lang, Real Money contributor and co-portfolio manager of Trifecta Stocks, and Chris Versace, Real Money contributor and co-portfolio manager of Trifecta Stocks on Pfizer and what the election of Joe Biden could mean for markets: